Protagonist Therapeutics, Inc. (PTGX) short interest & options flow
NASDAQPTGX cost to borrow spikes 143% in one week to 0.48%, signaling tightening loan availability despite short interest falling 9% over same period.
- Market cap
- $8.70B
- Next earnings
- 2 Nov 2026
Key data as of 20 Oct 2026
Latest signals on PTGX
- Cost to Borrow
PTGX cost to borrow spikes 143% in one week to 0.48%, signaling tightening loan availability despite short interest falling 9% over same period.
- Options
PTGX put-call ratio plunges to 0.48, nearly four standard deviations below its 20-day mean of 0.74, signaling extreme bullish sentiment in options markets.
PTGX news and analysis
RSSNo long-form analysis yet for PTGX. Pulse alerts and the live data picture are available on ORTEX.
Open PTGX on ORTEX →Want the live picture for PTGX?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for PTGX — free to start on ORTEX.
Sign up for free →Open PTGX on ORTEX